EZSCAN described as the most promising non-invasive screening for prediabetes product currently on the market
BusinessLab, a consultancy company based in UK, has made a study about EZSCAN through its collaborative action research programme ActiveAge.
The ActiveAge team has been looking into the need for screening and earlier diagnosis of pre-diabetes and the use of a non-invasive, two-minute test that provides immediate results, without the need for patient preparation or fasting. EZSCAN has been described as the most promising non-invasive screening for prediabetes product currently on the market.
The treatment of prediabetes and prevention of diabetes have been made a top-level priority by the Government of UK, healthcare professionals and general public.
To read the full report: